Savoy L A, Vuagnat P, Rose K, Halstrøm J, Jørgensen K H, Kovacs K
Département de Biochimie Médicale, Centre Médical Universitaire, Geneva, Switzerland.
Protein Eng. 1988 Oct;2(4):313-5. doi: 10.1093/protein/2.4.313.
The title compound was prepared by catalytic deiodination of (Tyr-A14-3-I) insulin with deuterium gas. Under special conditions (large excess of PdO in CH3OD/D2O at pH 9.2) developed to minimize problems due to poisoning of the catalyst, deuterated insulin was produced in yields of about 35% after purification by reversed phase HPLC. For analysis, the deuterated insulin was digested with V8 protease and was shown by mass spectrometry to have incorporated deuterium to an extent of 96.6 atom %, exclusively in a pentapeptide containing Tyr A14. The title compound should prove useful to those workers studying insulin by mass spectrometry, and use of the method with tritium gas in place of deuterium should permit the preparation of a specifically labelled radioactive insulin analogue which behaves identically to the natural hormone.
